Cargando…
Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies
Background The recommended dose of rasburicase is quite expensive, thus limiting its use. Whether a lower dose of rasburicase would be equally effective for critically ill children, who often have more complicated situations and a higher risk of hospital death, is still unknown. Objective To explore...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603475/ https://www.ncbi.nlm.nih.gov/pubmed/32974856 http://dx.doi.org/10.1007/s11096-020-01144-8 |